Pi, Jingbo
China Medical University Shenyang,
China
2025 Rank: 127286
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Toxicology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 479 out of 67220 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 127286 | 135250 |
| Total Cites | 998 | 1050 |
| H-index | 14 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 98 | 100 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 325 | 350 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 883 | 904 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.16 |
| Self-Citation Percentage |
4.95%
|
|
Pi, Jingbo
Ministry of Education of the People's Republic of China,
China
2024 Rank: 121582
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Toxicology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 475 out of 65055 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 121582 | 122444 |
| Total Cites | 928 | 1016 |
| H-index | 14 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 104 | 107 |
| Number of Single+First+Last Authored Papers | 82 | 82 |
| Total Cites to Single+First+Last Authored Papers | 334 | 361 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 823 | 865 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.17 |
| Self-Citation Percentage |
8.66%
|
|
Pi, Jingbo
China Medical University Shenyang,
China
2023 Rank: 123606
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Toxicology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 491 out of 61487 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 123606 | 122071 |
| Total Cites | 859 | 988 |
| H-index | 13 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 128 | 136 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 321 | 359 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 737 | 788 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.25 |
| Self-Citation Percentage |
13.06%
|
|
Pi, Jingbo
China Medical University Shenyang,
China
2022 Rank: 141389
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Toxicology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 589 out of 55990 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 141389 | 141533 |
| Total Cites | 603 | 670 |
| H-index | 11 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 154 | 157 |
| Number of Single+First+Last Authored Papers | 44 | 44 |
| Total Cites to Single+First+Last Authored Papers | 257 | 293 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 518 | 552 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
10.00%
|
|
Pi, Jingbo
China Medical University Shenyang,
China
2021 Rank: 113521
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Toxicology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 467 out of 53247 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 113521 | 111855 |
| Total Cites | 1154 | 1318 |
| H-index | 16 | 17 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 249 | 261 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 488 | 579 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 967 | 1034 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.27 |
| Self-Citation Percentage |
12.44%
|
|
Pi, Jingbo
China Medical University Shenyang,
China
2020 Rank: 102805
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Toxicology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 435 out of 45124 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102805 | 101164 |
| Total Cites | 899 | 1045 |
| H-index | 15 | 16 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 162 | 179 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 339 | 417 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 772 | 835 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.25 |
| Self-Citation Percentage |
13.97%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.